496 related articles for article (PubMed ID: 25758460)
1. Current advances in the generation of human iPS cells: implications in cell-based regenerative medicine.
Revilla A; González C; Iriondo A; Fernández B; Prieto C; Marín C; Liste I
J Tissue Eng Regen Med; 2016 Nov; 10(11):893-907. PubMed ID: 25758460
[TBL] [Abstract][Full Text] [Related]
2. Current reprogramming systems in regenerative medicine: from somatic cells to induced pluripotent stem cells.
Hu C; Li L
Regen Med; 2016 Jan; 11(1):105-32. PubMed ID: 26679838
[TBL] [Abstract][Full Text] [Related]
3. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
[TBL] [Abstract][Full Text] [Related]
4. iPS cell technology in regenerative medicine.
Lengner CJ
Ann N Y Acad Sci; 2010 Mar; 1192():38-44. PubMed ID: 20392216
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
[TBL] [Abstract][Full Text] [Related]
6. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
[TBL] [Abstract][Full Text] [Related]
7. Induced Pluripotent Stem Cells from Ovarian Tissue.
Salas S; Ng N; Gerami-Naini B; Anchan RM
Curr Protoc Hum Genet; 2017 Oct; 95():21.10.1-21.10.22. PubMed ID: 29044473
[TBL] [Abstract][Full Text] [Related]
8. Ten years of progress and promise of induced pluripotent stem cells: historical origins, characteristics, mechanisms, limitations, and potential applications.
Omole AE; Fakoya AOJ
PeerJ; 2018; 6():e4370. PubMed ID: 29770269
[TBL] [Abstract][Full Text] [Related]
9. Somatic cell reprogramming for regenerative medicine: SCNT vs. iPS cells.
Pan G; Wang T; Yao H; Pei D
Bioessays; 2012 Jun; 34(6):472-6. PubMed ID: 22419173
[TBL] [Abstract][Full Text] [Related]
10. Direct Reprogramming, Epigenetics, and Cardiac Regeneration.
Kurotsu S; Suzuki T; Ieda M
J Card Fail; 2017 Jul; 23(7):552-557. PubMed ID: 28529134
[TBL] [Abstract][Full Text] [Related]
11. Induced pluripotent stem (iPS) cells: a new source for cell-based therapeutics?
de Lázaro I; Yilmazer A; Kostarelos K
J Control Release; 2014 Jul; 185():37-44. PubMed ID: 24746625
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological Reprogramming of Somatic Cells for Regenerative Medicine.
Xie M; Tang S; Li K; Ding S
Acc Chem Res; 2017 May; 50(5):1202-1211. PubMed ID: 28453285
[TBL] [Abstract][Full Text] [Related]
13. Veterinary applications of induced pluripotent stem cells: regenerative medicine and models for disease?
Cebrian-Serrano A; Stout T; Dinnyes A
Vet J; 2013 Oct; 198(1):34-42. PubMed ID: 24129109
[TBL] [Abstract][Full Text] [Related]
14. Retroviral vector silencing during iPS cell induction: an epigenetic beacon that signals distinct pluripotent states.
Hotta A; Ellis J
J Cell Biochem; 2008 Nov; 105(4):940-8. PubMed ID: 18773452
[TBL] [Abstract][Full Text] [Related]
15. Concise Review: Application of Chemically Modified mRNA in Cell Fate Conversion and Tissue Engineering.
Badieyan ZS; Evans T
Stem Cells Transl Med; 2019 Aug; 8(8):833-843. PubMed ID: 30891922
[TBL] [Abstract][Full Text] [Related]
16. Future perspective of induced pluripotent stem cells for diagnosis, drug screening and treatment of human diseases.
Lian Q; Chow Y; Esteban MA; Pei D; Tse HF
Thromb Haemost; 2010 Jul; 104(1):39-44. PubMed ID: 20539907
[TBL] [Abstract][Full Text] [Related]
17. How far are induced pluripotent stem cells from the clinic?
Li M; Chen M; Han W; Fu X
Ageing Res Rev; 2010 Jul; 9(3):257-64. PubMed ID: 20362696
[TBL] [Abstract][Full Text] [Related]
18. Technological overview of iPS induction from human adult somatic cells.
Bayart E; Cohen-Haguenauer O
Curr Gene Ther; 2013 Apr; 13(2):73-92. PubMed ID: 23320476
[TBL] [Abstract][Full Text] [Related]
19. Genetic Manipulation by Zinc-Finger Nucleases in Rat-Induced Pluripotent Stem Cells.
Yang S; Ding S; Xu Q; Li X; Xiong Q
Cell Reprogram; 2017 Jun; 19(3):180-188. PubMed ID: 28339300
[TBL] [Abstract][Full Text] [Related]
20. Prospects of induced pluripotent stem cell technology in regenerative medicine.
Zhang F; Citra F; Wang DA
Tissue Eng Part B Rev; 2011 Apr; 17(2):115-24. PubMed ID: 21210760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
